Tag:
VIA-2291
Latest Headlines
Latest Headlines
VIA touts Phase II data
VIA Pharmaceuticals has released results from a sub-study of patients taking VIA-2291, the company's Phase II lead drug. Patients with acute coronary syndrome received medical imaging scans before
